# Alnylam Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 6, 2026

- Company: [Alnylam Pharmaceuticals, Inc.](/companies/alny.md) (CIK 1178670)
- Form: DEF 14A
- Filed: 2026-04-06
- Accepted by EDGAR: Apr 6, 2026, 16:30 ET
- Period: 2026-05-20
- Accession: 0001628280-26-023923
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1178670/000162828026023923/alny-20260406.htm

Filed Apr 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-023923. Last ingested by Listed: Oct 31, 2026, 15:25 ET. No prices; not investment advice.